nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—Alzheimer's disease	0.809	1	CbGaD
Ximelagatran—CYP2C9—Donepezil—Alzheimer's disease	0.124	1	CbGbCtD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—Alzheimer's disease	0.00027	0.00407	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000268	0.00404	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—APP—Alzheimer's disease	0.000267	0.00402	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000265	0.00399	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—CAV1—Alzheimer's disease	0.000265	0.00399	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.000264	0.00397	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TF—Alzheimer's disease	0.000262	0.00395	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.000257	0.00387	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ATP5A1—Alzheimer's disease	0.000256	0.00386	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.000252	0.0038	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000251	0.00378	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000248	0.00373	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000247	0.00372	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR6—Alzheimer's disease	0.000243	0.00366	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—GAB2—Alzheimer's disease	0.00024	0.00361	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.000239	0.0036	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—Alzheimer's disease	0.000236	0.00355	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—SLC30A6—Alzheimer's disease	0.000234	0.00353	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—APP—Alzheimer's disease	0.000234	0.00352	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000227	0.00342	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CDK5—Alzheimer's disease	0.000226	0.0034	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000225	0.0034	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000224	0.00338	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000221	0.00332	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TPP1—Alzheimer's disease	0.000218	0.00328	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000218	0.00328	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—Alzheimer's disease	0.000213	0.00322	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—Alzheimer's disease	0.00021	0.00317	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000208	0.00313	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—Alzheimer's disease	0.000202	0.00305	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GAL—Alzheimer's disease	0.000202	0.00304	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	0.000201	0.00303	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.00019	0.00287	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00019	0.00287	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000188	0.00283	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000187	0.00282	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000184	0.00278	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000181	0.00274	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000181	0.00273	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CLU—Alzheimer's disease	0.000178	0.00269	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000178	0.00268	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000177	0.00267	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000176	0.00265	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.000174	0.00263	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ADAMTS4—Alzheimer's disease	0.000174	0.00262	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000173	0.0026	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—Alzheimer's disease	0.000171	0.00258	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.00017	0.00256	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PYY—Alzheimer's disease	0.000164	0.00248	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000163	0.00246	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—Alzheimer's disease	0.000159	0.0024	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—A2M—Alzheimer's disease	0.000159	0.00239	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPY—Alzheimer's disease	0.000158	0.00239	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—IAPP—Alzheimer's disease	0.000157	0.00237	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000155	0.00233	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CRH—Alzheimer's disease	0.000153	0.0023	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—Alzheimer's disease	0.000151	0.00227	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PYY—Alzheimer's disease	0.000149	0.00225	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPS—Alzheimer's disease	0.000145	0.00218	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MME—Alzheimer's disease	0.000142	0.00214	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000141	0.00213	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SST—Alzheimer's disease	0.000138	0.00208	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—Alzheimer's disease	0.000138	0.00208	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000137	0.00207	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—INPP5D—Alzheimer's disease	0.000137	0.00206	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—Alzheimer's disease	0.000136	0.00205	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TF—Alzheimer's disease	0.000135	0.00204	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—APP—Alzheimer's disease	0.000135	0.00203	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000133	0.00201	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—HSPD1—Alzheimer's disease	0.000132	0.00199	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000132	0.00198	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CDK5—Alzheimer's disease	0.000129	0.00195	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000127	0.00191	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR6—Alzheimer's disease	0.000125	0.00188	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—GAB2—Alzheimer's disease	0.000124	0.00186	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000123	0.00186	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APP—Alzheimer's disease	0.00012	0.00181	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000117	0.00176	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000116	0.00175	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000114	0.00172	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000114	0.00172	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EIF2S1—Alzheimer's disease	0.000111	0.00168	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—Alzheimer's disease	0.00011	0.00165	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACHE—Alzheimer's disease	0.000109	0.00164	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GAL—Alzheimer's disease	0.000103	0.00156	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTSD—Alzheimer's disease	0.000103	0.00155	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000103	0.00155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TTR—Alzheimer's disease	0.000101	0.00152	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	9.98e-05	0.0015	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—Alzheimer's disease	9.82e-05	0.00148	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	9.78e-05	0.00147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.65e-05	0.00145	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GSK3A—Alzheimer's disease	9.64e-05	0.00145	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—BCHE—Alzheimer's disease	9.47e-05	0.00143	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF2—Alzheimer's disease	9.32e-05	0.00141	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	9.18e-05	0.00138	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—Alzheimer's disease	9.18e-05	0.00138	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPY—Alzheimer's disease	8.95e-05	0.00135	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	8.94e-05	0.00135	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR5—Alzheimer's disease	8.91e-05	0.00134	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IAPP—Alzheimer's disease	8.9e-05	0.00134	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PYY—Alzheimer's disease	8.82e-05	0.00133	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2A—Alzheimer's disease	8.72e-05	0.00131	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CRH—Alzheimer's disease	8.64e-05	0.0013	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.47e-05	0.00128	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PRKCG—Alzheimer's disease	8.4e-05	0.00127	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPS—Alzheimer's disease	8.19e-05	0.00123	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPY—Alzheimer's disease	8.13e-05	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IAPP—Alzheimer's disease	8.08e-05	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CRH—Alzheimer's disease	7.84e-05	0.00118	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GAB2—Alzheimer's disease	7.81e-05	0.00118	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SST—Alzheimer's disease	7.81e-05	0.00118	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDK5—Alzheimer's disease	7.65e-05	0.00115	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—APP—Alzheimer's disease	7.61e-05	0.00115	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	7.59e-05	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPS—Alzheimer's disease	7.43e-05	0.00112	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP3CA—Alzheimer's disease	7.4e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR6—Alzheimer's disease	7.36e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—Alzheimer's disease	7.35e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF2—Alzheimer's disease	7.34e-05	0.00111	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CALM1—Alzheimer's disease	7.27e-05	0.0011	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PLCB1—Alzheimer's disease	7.18e-05	0.00108	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAV1—Alzheimer's disease	7.18e-05	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GAB2—Alzheimer's disease	7.09e-05	0.00107	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SST—Alzheimer's disease	7.09e-05	0.00107	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	6.96e-05	0.00105	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—APP—Alzheimer's disease	6.91e-05	0.00104	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—Alzheimer's disease	6.81e-05	0.00103	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—Alzheimer's disease	6.75e-05	0.00102	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSENEN—Alzheimer's disease	6.68e-05	0.00101	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APH1A—Alzheimer's disease	6.59e-05	0.000993	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PLCB1—Alzheimer's disease	6.52e-05	0.000983	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCSTN—Alzheimer's disease	6.42e-05	0.000967	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LRP1—Alzheimer's disease	6.26e-05	0.000943	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GFAP—Alzheimer's disease	6.11e-05	0.000921	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GAL—Alzheimer's disease	6.11e-05	0.000921	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—Alzheimer's disease	5.99e-05	0.000902	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—Alzheimer's disease	5.7e-05	0.000859	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	5.65e-05	0.000852	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—Alzheimer's disease	5.43e-05	0.000818	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—A2M—Alzheimer's disease	5.39e-05	0.000812	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	5.36e-05	0.000808	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.31e-05	0.0008	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.27e-05	0.000794	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSEN2—Alzheimer's disease	5.22e-05	0.000786	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—Alzheimer's disease	5.03e-05	0.000758	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2A—Alzheimer's disease	4.93e-05	0.000742	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INS—Alzheimer's disease	4.87e-05	0.000734	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	4.84e-05	0.000729	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRKCG—Alzheimer's disease	4.82e-05	0.000727	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA4—Alzheimer's disease	4.81e-05	0.000724	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPY—Alzheimer's disease	4.8e-05	0.000724	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—Alzheimer's disease	4.79e-05	0.000722	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IAPP—Alzheimer's disease	4.77e-05	0.000719	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—Alzheimer's disease	4.71e-05	0.00071	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.7e-05	0.000708	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CRH—Alzheimer's disease	4.63e-05	0.000698	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—Alzheimer's disease	4.57e-05	0.000689	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	4.52e-05	0.000681	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2A—Alzheimer's disease	4.47e-05	0.000674	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPS—Alzheimer's disease	4.39e-05	0.000662	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP3CA—Alzheimer's disease	4.37e-05	0.000659	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTK2B—Alzheimer's disease	4.31e-05	0.000649	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	4.29e-05	0.000646	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GAB2—Alzheimer's disease	4.19e-05	0.000631	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SST—Alzheimer's disease	4.19e-05	0.000631	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—Alzheimer's disease	4.19e-05	0.000631	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CALM1—Alzheimer's disease	4.17e-05	0.000629	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3A—Alzheimer's disease	4.15e-05	0.000626	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLD3—Alzheimer's disease	4.09e-05	0.000616	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.09e-05	0.000616	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APP—Alzheimer's disease	4.08e-05	0.000615	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.04e-05	0.000609	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.92e-05	0.000591	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—Alzheimer's disease	3.91e-05	0.000589	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLCB1—Alzheimer's disease	3.85e-05	0.000581	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.83e-05	0.000577	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.77e-05	0.000569	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.64e-05	0.000549	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGFR—Alzheimer's disease	3.59e-05	0.000542	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—Alzheimer's disease	3.59e-05	0.000541	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CREB1—Alzheimer's disease	3.57e-05	0.000538	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.56e-05	0.000537	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADAM10—Alzheimer's disease	3.51e-05	0.000529	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—Alzheimer's disease	3.5e-05	0.000527	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S100B—Alzheimer's disease	3.32e-05	0.0005	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.26e-05	0.000491	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF2—Alzheimer's disease	3.16e-05	0.000476	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—Alzheimer's disease	3.06e-05	0.000461	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—Alzheimer's disease	2.95e-05	0.000445	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LPL—Alzheimer's disease	2.93e-05	0.000442	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MEF2C—Alzheimer's disease	2.9e-05	0.000438	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCG—Alzheimer's disease	2.85e-05	0.000429	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.81e-05	0.000423	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGF—Alzheimer's disease	2.78e-05	0.000418	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—Alzheimer's disease	2.7e-05	0.000407	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2A—Alzheimer's disease	2.64e-05	0.000398	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.56e-05	0.000385	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—Alzheimer's disease	2.5e-05	0.000376	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CALM1—Alzheimer's disease	2.47e-05	0.000371	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—Alzheimer's disease	2.46e-05	0.00037	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—Alzheimer's disease	2.46e-05	0.00037	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—Alzheimer's disease	2.43e-05	0.000367	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.35e-05	0.000354	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.35e-05	0.000354	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—Alzheimer's disease	2.35e-05	0.000353	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.27e-05	0.000342	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.25e-05	0.000339	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	2.17e-05	0.000327	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.14e-05	0.000323	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3B—Alzheimer's disease	2.13e-05	0.000321	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.12e-05	0.00032	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CREB1—Alzheimer's disease	2.11e-05	0.000318	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INS—Alzheimer's disease	2.1e-05	0.000316	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—A2M—Alzheimer's disease	2.09e-05	0.000315	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—Alzheimer's disease	2.06e-05	0.000311	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—Alzheimer's disease	2.03e-05	0.000306	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.87e-05	0.000281	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—Alzheimer's disease	1.84e-05	0.000277	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.82e-05	0.000274	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.8e-05	0.000271	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.71e-05	0.000257	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.71e-05	0.000257	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.67e-05	0.000252	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.59e-05	0.000239	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.58e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—Alzheimer's disease	1.56e-05	0.000235	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—Alzheimer's disease	1.55e-05	0.000234	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.5e-05	0.000226	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.47e-05	0.000221	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.45e-05	0.000219	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK8—Alzheimer's disease	1.44e-05	0.000216	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—Alzheimer's disease	1.43e-05	0.000216	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—Alzheimer's disease	1.33e-05	0.0002	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.25e-05	0.000188	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.24e-05	0.000188	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—Alzheimer's disease	1.22e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.14e-05	0.000172	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.02e-05	0.000154	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—Alzheimer's disease	1e-05	0.000151	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CALM1—Alzheimer's disease	9.57e-06	0.000144	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—Alzheimer's disease	9.54e-06	0.000144	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—Alzheimer's disease	9.45e-06	0.000142	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—Alzheimer's disease	9.17e-06	0.000138	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—Alzheimer's disease	8.46e-06	0.000127	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—Alzheimer's disease	8.31e-06	0.000125	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INS—Alzheimer's disease	8.15e-06	0.000123	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—Alzheimer's disease	7.15e-06	0.000108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	6.54e-06	9.85e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—Alzheimer's disease	3.29e-06	4.95e-05	CbGpPWpGaD
